Trademark: 79287862
Word
BOTULIZ
Status
Registered
Status Code
700
Status Date
Tuesday, July 6, 2021
Serial Number
79287862
Registration Number
6405721
Registration Date
Tuesday, July 6, 2021
Mark Type
5000
Filing Date
Thursday, April 23, 2020
Published for Opposition
Tuesday, April 20, 2021

Trademark Owner History
JETEMA CO., LTD. - Original Registrant

Classifications
5 Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating muscle disorders; pharmaceutical agents affecting metabolism; bacterial poisons; anaesthetics; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for treating middle of the forehead wrinkles; pharmaceutical preparations for use in the cosmetic field, namely, medicated cosmetics; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for the treatment of urogenital organ disorders; pharmaceutical preparations for plastic surgery; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; veterinary substances and preparations for house pets for injuries pain, namely, pharmaceuticals containing botulinum toxin; cardiovascular agents for medical purposes; pharmaceutical preparations for treating neurological disorders; ophthalmic preparations; pharmaceutical preparations for treating facial cramps; allergy medications; chemical preparations for pharmaceutical purposes, namely, for neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; chemico-pharmaceutical preparations, namely, for neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for treating facial wrinkles; pharmaceutical agents for epidermis; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; medicines for human purposes, namely, pharmaceutical preparations for the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for treating middle of the forehead wrinkles, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for treating orthopaedic purposes; pharmaceutical preparations acting on the central nervous system; analgesic preparations; medicines for dental purposes; therapeutic drugs and agents as pharmaceuticals for treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for treating pain; pharmaceutical products for skin care for medical purposes, namely, botulinum toxin, botulinum toxin-hemagglutinin complex, botulinum toxin fragments and other derivatives; pharmaceutical preparations for treating neurological diseases, namely, botulinum toxin, botulinum toxin-hemagglutinin complex, botulinum toxin fragments and other derivatives; pharmaceutical preparation for skin care; medicated skin preparation for use in treating wrinkles; pharmaceutical preparations for treatment of respiratory organ disorder; preparations for the treatment of burns; preparations for the treatment of scar
Color is not claimed as a feature of the mark.

Trademark Events
Oct 6, 2023
New Representative At Ib Received
Nov 23, 2021
Final Decision Transaction Processed By Ib
Nov 3, 2021
Final Disposition Notice Sent To Ib
Nov 3, 2021
Final Disposition Processed
Oct 6, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jul 6, 2021
Registered-Principal Register
Apr 20, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 20, 2021
Published For Opposition
Apr 18, 2021
Notification Processed By Ib
Apr 9, 2021
New Representative At Ib Received
Mar 31, 2021
Notification Of Possible Opposition Sent To Ib
Mar 31, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 31, 2021
Notification Of Notice Of Publication E-Mailed
Mar 18, 2021
Approved For Pub - Principal Register
Mar 18, 2021
Examiner's Amendment Entered
Mar 18, 2021
Notification Of Examiners Amendment E-Mailed
Mar 18, 2021
Examiners Amendment E-Mailed
Mar 18, 2021
Examiners Amendment -Written
Feb 25, 2021
Teas/Email Correspondence Entered
Feb 24, 2021
Correspondence Received In Law Office
Feb 24, 2021
Teas Response To Office Action Received
Feb 5, 2021
New Representative At Ib Received
Sep 27, 2020
Refusal Processed By Ib
Sep 5, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Aug 24, 2020
Refusal Processed By Mpu
Jul 17, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Jul 16, 2020
Non-Final Action Written
Jul 15, 2020
Assigned To Examiner
Jun 23, 2020
Application Filing Receipt Mailed
Jun 19, 2020
New Application Office Supplied Data Entered
Jun 18, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24